Security
QSIAW · Hyperfine, Inc.
QSIAWNASDAQWarrantHistorical · closed Dec 22, 2021CIK 1833769Updated Sep 24, 2026
Name history
HealthCor Catalio Acquisition Corp. · through Dec 22, 2021
Current security for this SEC filerHYPR · NASDAQ
QSIAW price & chart
Historical security
This listing closed Dec 22, 2021. Live provider charts are shown only for current listings.
Current security: HYPR
About the company
Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system - the first U.S. Food and Drug Administration (FDA)-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of professional care. The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. For more information, visit hyperfine.io.
In the news
No coverage from other publishers is available.
Recent filings
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Items 3.01
4 filing
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 55,262,000Source | 58,901,000Source | 94,199,000Source | 134,051,000Source |
| Property, Plant and Equipment, NetUSD | 2,549,000Source | 3,122,000Source | 2,999,000Source | 3,248,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 35,085,000Source | 37,645,000Source | 75,183,000Source | 117,472,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 5,254,000Source | 5,956,000Source | 3,189,000Source | 2,103,000Source |
| Inventory, NetUSD | 7,090,000Source | 5,832,000Source | 6,582,000Source | 4,622,000Source |
| Assets, CurrentUSD | 50,909,000Source | 53,710,000Source | 88,908,000Source | 128,664,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,255,000Source | 1,900,000Source | 2,391,000Source | 3,194,000Source |
| Operating Lease, Right-of-Use AssetUSD | 316,000Source | 341,000Source | 239,000Source | — |
| Other Assets, NoncurrentUSD | 1,804,000Source | 2,069,000Source | 2,292,000Source | 2,139,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 14,257,000Source | 9,861,000Source | 9,800,000Source | 10,329,000Source |
| Stockholders’ equity: | ||||
| Additional Paid in CapitalUSD | 371,011,000Source | 343,475,000Source | 338,114,000Source | 333,199,000Source |
| Retained Earnings (Accumulated Deficit)USD | -330,016,000Source | -294,442,000Source | -253,722,000Source | -209,484,000Source |
| Stockholders' Equity Attributable to ParentUSD | 41,005,000Source | 49,040,000Source | 84,399,000Source | 123,722,000Source |
| Liabilities and EquityUSD | 55,262,000Source | 58,901,000Source | 94,199,000Source | 134,051,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 11,732,000Source | 8,729,000Source | 8,768,000Source | 8,803,000Source |
| Operating Lease, Liability, CurrentUSD | 248,000Source | 269,000Source | 185,000Source | — |
| Accounts Payable, CurrentUSD | 4,051,000Source | 1,607,000Source | 1,214,000Source | 678,000Source |
| Operating Lease, Liability, NoncurrentUSD | 66,000Source | 78,000Source | 64,000Source | — |
| Other Liabilities, NoncurrentUSD | 66,000Source | 78,000Source | 64,000Source | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -35,574,000Source | -40,720,000Source | -44,238,000Source | -73,164,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | 1,015,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,801,000Source | 4,362,000Source | 4,741,000Source | 10,652,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -702,000Source | 2,767,000Source | 1,086,000Source | 1,550,000Source |
| Increase (Decrease) in InventoriesUSD | 1,475,000Source | -562,000Source | 2,209,000Source | 312,000Source |
| Increase (Decrease) in Accounts PayableUSD | 2,427,000Source | 382,000Source | 533,000Source | -1,570,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -27,948,000Source | -38,767,000Source | -41,809,000Source | -72,339,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,185,000Source | -383,000Source | -804,000Source | -585,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,185,000Source | 383,000Source | 804,000Source | 585,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 27,502,000Source | 1,019,000Source | 174,000Source | 7,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 36,042,000Source | 37,673,000Source | 75,804,000Source | 118,243,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 0Source | — | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 2,801,000Source | 4,362,000Source | 4,741,000Source | 10,652,000Source |
| DepreciationUSD | 1,090,000Source | 1,009,000Source | 1,054,000Source | 1,015,000Source |
| General and Administrative ExpenseUSD | 16,253,000Source | 17,494,000Source | 20,276,000Source | 32,406,000Source |
| Impairment of Intangible Assets, Finite-livedUSD | 0Source | 0Source | 0Source | 80,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Investment Income, InterestUSD | 1,023,000Source | 2,492,000Source | 3,842,000Source | 761,000Source |
| Net Income (Loss) Attributable to ParentUSD | -35,574,000Source | -40,720,000Source | -44,238,000Source | -73,164,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -35,574,000Source | -40,720,000Source | -44,238,000Source | -73,164,000Source |
| Operating ExpensesUSD | 43,838,000Source | 49,115,000Source | 52,872,000Source | 74,781,000Source |
| Other Nonoperating Income (Expense)USD | -337,000Source | 12,000Source | 35,000Source | -51,000Source |
| Proceeds from Stock Options ExercisedUSD | 156,000Source | 171,000Source | 174,000Source | 7,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 13,563,000Source | 12,890,000Source | 11,032,000Source | 6,814,000Source |
| Cost of RevenueUSD | 6,810,000Source | 6,999,000Source | 6,275,000Source | 5,907,000Source |
| Operating Income (Loss)USD | -37,085,000Source | -43,224,000Source | -48,115,000Source | -73,874,000Source |
| Other Nonoperating Income (Expense)USD | -337,000Source | 12,000Source | 35,000Source | -51,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -35,574,000Source | -40,720,000Source | -44,238,000Source | -73,164,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -35,574,000Source | -40,720,000Source | -44,238,000Source | -73,164,000Source |
| Earnings Per Share, BasicUSD per share | -0.43Source | -0.56Source | -0.62Source | -1.04Source |
| Earnings Per Share, DilutedUSD per share | -0.43Source | -0.56Source | -0.62Source | -1.04Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 81,795,105Source | 72,413,541Source | 71,316,424Source | 70,449,191Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 81,795,105Source | 72,413,541Source | 71,316,424Source | 70,449,191Source |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 16,253,000Source | 17,494,000Source | 20,276,000Source | 32,406,000Source |
| Gross ProfitUSD | 6,753,000Source | 5,891,000Source | 4,757,000Source | 907,000Source |
| Investment Income, InterestUSD | 1,023,000Source | 2,492,000Source | 3,842,000Source | 761,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -35,574,000Source | -40,720,000Source | -44,238,000Source | -73,164,000Source |
| Operating ExpensesUSD | 43,838,000Source | 49,115,000Source | 52,872,000Source | 74,781,000Source |
| Research and Development ExpenseUSD | 17,451,000Source | 22,499,000Source | 22,493,000Source | 28,156,000Source |
| Selling and Marketing ExpenseUSD | 10,134,000Source | 9,122,000Source | 10,103,000Source | 14,219,000Source |
Filing attachments
hypr-ex99_1.htm · 8-K · 2026-08-06
EX-99.1 2 hypr-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Hyperfine, Inc. Reports Second Quarter 2026 Financial Results GUILFORD, Connecticut, August 6, 2026 (GLOBE NEWSWIRE) - Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system - the Swoop® system - today announced second quarter 2026 financial results and provided a business update. “Q2 was …
Read attachment ↗hypr-ex99_1.htm · 8-K · 2026-05-12
EX-99.1 2 hypr-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Hyperfine, Inc. Reports First Quarter 2026 Financial Results GUILFORD, Connecticut, May 12, 2026 (GLOBE NEWSWIRE) - Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system - the Swoop® system - today announced first quarter 2026 financial results and provided a business update. “Our executi…
Read attachment ↗d86022dex41.htm · 8-K · 2026-03-18
EX-4.1 2 d86022dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 THE OFFER AND SALE OF THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAW. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, EXCEPT PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT, INCLUDING PURSUANT TO RULE 144 UNDER THE ACT OR PURSUANT …
Read attachment ↗d86022dex42.htm · 8-K · 2026-03-18
EX-4.2 3 d86022dex42.htm EX-4.2 EX-4.2 Exhibit 4.2 THE OFFER AND SALE OF THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAW. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, EXCEPT PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT, INCLUDING PURSUANT TO RULE 144 UNDER THE ACT OR PURSUANT …
Read attachment ↗hypr-ex99_1.htm · 8-K · 2026-03-18
EX-99.1 2 hypr-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results GUILFORD, Connecticut, March 18, 2026 (GLOBE NEWSWIRE) - Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system - the Swoop® system - today announced fourth quarter and full year 2025 financial results and provided …
Read attachment ↗